Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis
- PMID: 17701094
- DOI: 10.1007/s00198-007-0437-6
Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis
Abstract
Fluoride has fallen into discredit due to the absence of an anti-fracture effect. However, in this meta-analysis, a fracture reducing potential was seen at low fluoride doses [< or =20 mg fluoride equivalents (152 mg monofluorophosphate/44 mg sodium fluoride)]: OR = 0.3, 95% CI: 0.1-0.9 for vertebral and OR = 0.5, 95% CI: 0.3-0.8 for non-vertebral fractures.
Introduction: Fluoride is incorporated into bone mineral and has an anabolic effect. However, the biomechanical competence of the newly formed bone may be reduced.
Methods: A systematic search of PubMed, Embase, and ISI web of science yielded 2,028 references.
Results: Twenty-five eligible studies were identified. Spine BMD increased 7.9%, 95% CI: 5.4-10.5%, and hip BMD 2.1%, 95% CI: 0.9-3.4%. A meta-regression showed increasing spine BMD with increasing treatment duration (5.04 +/- 2.16%/year of treatment). Overall there was no significant effect on the risk of vertebral (OR = 0.8, 95% CI: 0.5-1.5) or non-vertebral fracture (OR = 0.8, 95% CI: 0.5-1.4). With a daily dose of < or =20 mg fluoride equivalents (152 mg monofluorophosphate/44 mg sodium fluoride), there was a statistically significant reduction in vertebral (OR = 0.3, 95% CI: 0.1-0.9) and non-vertebral (OR = 0.5, 95% CI: 0.3-0.8) fracture risk. With a daily dose >20 mg fluoride equivalents, there was no significant reduction in vertebral (OR = 1.3, 95% CI: 0.8-2.0) and non-vertebral (OR = 1.5, 95% CI: 0.8-2.8) fracture risk.
Conclusions: Fluoride treatment increases spine and hip BMD, depending on treatment duration. Overall there was no effect on hip or spine fracture risk. However, in subgroup analyses a low fluoride dose (< or =20 mg/day of fluoride equivalents) was associated with a significant reduction in fracture risk.
Similar articles
-
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.Ann Intern Med. 1998 Jul 1;129(1):1-8. doi: 10.7326/0003-4819-129-1-199807010-00001. Ann Intern Med. 1998. PMID: 9652994 Clinical Trial.
-
Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.Osteoporos Int. 1999;9(2):171-8. doi: 10.1007/s001980050132. Osteoporos Int. 1999. PMID: 10367046 Clinical Trial.
-
Water fluoridation and osteoporotic fracture.Community Dent Health. 1996 Sep;13 Suppl 2:63-8. Community Dent Health. 1996. PMID: 8897754 Review.
-
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.Osteoporos Int. 2007 Jan;18(1):45-57. doi: 10.1007/s00198-006-0204-0. Epub 2006 Sep 2. Osteoporos Int. 2007. PMID: 16951908 Review.
-
Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis.Osteoporos Int. 2000;11(9):727-38. doi: 10.1007/s001980070051. Osteoporos Int. 2000. PMID: 11148800
Cited by
-
Bioactive glass-ceramics containing fluorapatite, xonotlite, cuspidine and wollastonite form apatite faster than their corresponding glasses.Sci Rep. 2024 Feb 18;14(1):3997. doi: 10.1038/s41598-024-54228-0. Sci Rep. 2024. PMID: 38369547 Free PMC article.
-
Community Water Fluoridation and Rate of Pediatric Fractures.J Am Acad Orthop Surg Glob Res Rev. 2023 Oct 5;7(10):e22.00221. doi: 10.5435/JAAOSGlobal-D-22-00221. eCollection 2023 Oct 1. J Am Acad Orthop Surg Glob Res Rev. 2023. PMID: 37796978 Free PMC article.
-
The Role of Trace Elements and Minerals in Osteoporosis: A Review of Epidemiological and Laboratory Findings.Biomolecules. 2023 Jun 17;13(6):1006. doi: 10.3390/biom13061006. Biomolecules. 2023. PMID: 37371586 Free PMC article. Review.
-
Patterns of fluoride intake from 6 to 17 years of age: The Iowa Fluoride Study.J Public Health Dent. 2023 Mar;83(1):18-25. doi: 10.1111/jphd.12542. Epub 2022 Oct 17. J Public Health Dent. 2023. PMID: 36251680 Free PMC article.
-
Effects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells.Cells. 2021 Sep 10;10(9):2383. doi: 10.3390/cells10092383. Cells. 2021. PMID: 34572032 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
